ePharmaSolutions is committed to helping sponsors, contract research organizations and investigative sites to streamline and accelerate clinical trials. We harness the power of technology to help you cut through clutter, manage documents effortlessly, and standardize workflow.

Innovation can be inspiring, but it can also compete with the realities of daily trial management. Let ePS help you build a healthier tomorrow by providing the clever, unexpected solutions that you need today.

ePharmaONE

The portal allows you to:

  • Consolidate navigation to active study workspaces
  • Easily identify actions required to be completed through centralized task management
  • Provide simple, unified user provisioning
  • Centralize study calendar events
  • Link to third-party websites/applications
  • Enforce access rights to system applications based on training completion status
  • Collaborate on content utilizing a secure document repository

With ePharmaONE, choose from any of these solutions to drive efficiencies and accelerate timelines in your clinical trials:

The Learning Management System (LMS) manages the administration, documentation, tracking, reporting and delivery of online training used in clinical trials. It allows for role-based training programs to tailor specific training to each role. Key benefits include:

  • Host sharable content object reference model (SCORM)-compliant e-Learning modules and archives of online meetings
  • Automatically generate certificates to document completion of training
  • Provide training reports to study teams to monitor sites’ training progress
  • Track externally completed training
The Secure Document Exchange (SDE) is an electronic document management system allowing sites to negotiate, finalize and digitally sign all study-specific, contractual and regulated documents. Sponsors and CROs can oversee the accurate completion and collection of all essential documents. Key benefits include:

  • Allow the revision and approval of documents within the system to reduce duplicate work
  • Ensure all documents are stored within one system
  • Reduce the time and fees associated with updating and mailing documents
  • Provide visibility of non-responsive sites
  • Track completion of documents to accelerate study start-up, conduct, and close-out
  • Allow for migration of documents into the electronic Trial Master File (eTMF)
Key benefits include:

The electronic Trial Master File (eTMF) application allows study teams to manage all essential documents to support the execution of a clinical trial based upon a defined reference model. Expected, missing, and expiring documents are simple to find and reconcile.

  • Automate configurations of reference model, best practices metadata values and document folder structures
  • Accelerate document upload, approval and quality checks (QC) using intelligent bulk processing
  • Improve visibility for expected/missing/expired content through standard document checklists
  • Ensure inspection readiness by providing robust standard reporting
  • Provide a single source of truth for all your approved TMF content
  • Permit detailed searching of documents based on document name, metadata or content
Key benefits include:

The Site Feasibility Application (SFA) allows sponsors and CROs to identify sites to participate in a clinical trial. Potential sites may be contacted through a centralized user repository which has the capability to leverage historical site information. Custom questionnaires may be created for each protocol to collect key information which can be weighted to help identify the best responses. Detailed reports are available for feasibility teams to analyze the data, aiding in the selection of the sites best suited for studies.

  • Ease of tracking responders and non-responders
  • Centralized management of responses
  • Automated ranking of sites based on scoring algorithms
  • Reduced site burden through pre-population of responses based on previous surveys
Safety Letter Distribution (SLD) is an automated solution to the safety document distribution process which allows SUSARs, Investigator Brochures (IB), and other safety related reports to be disseminated to investigative sites globally in real time with the click of a button. Investigative sites are notified of new distributions via an email notification from which they can conveniently and securely access, review, and acknowledge their assigned safety documents. All acknowledgements are automatically tracked, providing the ability to report on and assist with site compliance. Key benefits include:

  • Accelerate and automate the distribution and tracking of safety documents
  • Fulfill varying regulatory rules, by defining targeted lists of sites to receive distributions (Global, Region, Country)
  • Support sites in maintaining compliance through the use of reminder notifications
  • Simplify site activation through the automated distribution of the latest IB and SUSARs to new sites
  • Assist sites by allowing a study team member to perform an offline review on their behalf
  • Automatically send safety documents to the Trial Master File
  • Easily resolve a document distributed in error, simply by cancelling the distribution

ePS Learn

ePS is the official training partner of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), a non-profit, educational organization dedicated to enhancing the research, diagnosis, and treatment of these conditions. Together with GRAPPA, ePS has built a catalog of online learning courses for clinicians working in psoriasis and psoriatic arthritis research and development, which has helped to standardize the use of rating scales and improve endpoint reliability in studies with subjective endpoints.

Total Feasibility

It begins with WCG Predict, allowing the leading data intelligence source to provide predictive and actionable intelligence to the sponsor so they can make the right investigator choice. WCG Predict is followed by WCG Feasibility, which uses the predictive and actionable investigator information to reach out to those sponsor-chosen high performers within an electronic system that collates and organizes investigator responses in real time, making them available instantaneously. Key benefits include:

  • Providing sponsors the highest probably of choosing investigators who are likely to be high enrollers on their upcoming study
  • Introducing sponsors to investigators that they are not familiar with, but are experienced and high-performing in the therapeutic area they are researching
  • An external Data Engine that organizes all clinical trial information, so sponsor’s don’t have to
  • Streamlined feasibility outreach and follow-up service, reducing the clinical teams’ burden while driving in responses
  • More information about investigators’ enrollment performance than any entity in North America